OUR EDITORIAL STANDARDS

Evidence before publication

Draft policy ยท Pending publisher and clinical review.

Primary sources, original summaries

Summaries are written from Drugs@FDA, official FDA communications, and ClinicalTrials.gov where relevant. Commercial guides, layouts, and artwork are not reproduced.

Drugs@FDA
ClinicalTrials.gov

One record, one product

Brand, ingredient, formulation, route, and labeled indication must be verified individually. Every approved-product entry must link to its own verified FDA prescribing information. A Medication Guide is linked only when verified. Ingredient matches never transfer labeling between products.

Review is a prerequisite

Records progress through draft, in review, published, and archived states. Publication requires a verified FDA primary-source link, a named reviewer, a review date, and a last-verified date. Approved-product records also require their own label and verified product details. Unpublished records are excluded from public search and shared links.

Boundaries and updates

No individual dosing recommendations, treatment instructions, product sales, or affiliate links are included. Clinical entries require a live internet connection. Reviewers must recheck official sources before publication and whenever a material labeling or regulatory change is identified.